blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1436294

EP1436294 - TETRACYCLIC AZAINDOLES AND -INDOLINES HAVING SEROTONIN 5-HT2C ACTIVITY [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  26.05.2006
Database last updated on 05.10.2024
Most recent event   Tooltip26.05.2006Application deemed to be withdrawnpublished on 28.06.2006  [2006/26]
Applicant(s)For all designated states
Pharmacia & Upjohn Company LLC
301 Henrietta Street
Kalamazoo, MI 49001 / US
[2005/18]
Former [2004/29]For all designated states
PHARMACIA & UPJOHN COMPANY
301 Henrietta Street
Kalamazoo, Michigan 49001 / US
Inventor(s)01 / FU, Jian-Min
5123 Heathrow Avenue
Kalamazoo, MI 49009 / US
 [2004/29]
Representative(s)Perry, Robert Edward
Gill Jennings & Every LLP The Broadgate Tower
20 Primrose Street
London
EC2A 2ES / GB
[N/P]
Former [2004/29]Perry, Robert Edward
GILL JENNINGS & EVERY Broadgate House 7 Eldon Street
London EC2M 7LH / GB
Application number, filing date02773791.515.10.2002
[2004/29]
WO2002US33176
Priority number, dateUS20010335081P18.10.2001         Original published format: US 335081 P
[2004/29]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03033497
Date:24.04.2003
Language:EN
[2003/17]
Type: A1 Application with search report 
No.:EP1436294
Date:14.07.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 24.04.2003 takes the place of the publication of the European patent application.
[2004/29]
Search report(s)International search report - published on:EP24.04.2003
ClassificationIPC:C07D471/06, A61K31/55, A61K31/535, A61P25/00
[2004/29]
CPC:
C07D498/22 (EP,US); A61P25/00 (EP); A61P25/22 (EP);
A61P25/24 (EP); A61P3/04 (EP); C07D513/22 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2004/29]
Extension statesAL05.05.2004
LT05.05.2004
LV05.05.2004
MK05.05.2004
RO05.05.2004
SI05.05.2004
TitleGerman:TETRACYCLISCHE AZAINDOLE UND -INDOLINE MIT SEROTONIN 5-HT2C AKTIVITÄT[2004/29]
English:TETRACYCLIC AZAINDOLES AND -INDOLINES HAVING SEROTONIN 5-HT2C ACTIVITY[2004/29]
French:TETRACYCLIQUES AZAINDOLES ET INDOLINES MODULANT L'ACTIVITE DE 5-HT[2004/29]
Entry into regional phase05.05.2004National basic fee paid 
05.05.2004Designation fee(s) paid 
05.05.2004Examination fee paid 
Examination procedure12.05.2003Request for preliminary examination filed
International Preliminary Examining Authority: US
05.05.2004Amendment by applicant (claims and/or description)
05.05.2004Examination requested  [2004/29]
11.08.2004Despatch of a communication from the examining division (Time limit: M06)
27.05.2005Reply to a communication from the examining division
30.06.2005Despatch of a communication from the examining division (Time limit: M06)
11.01.2006Application deemed to be withdrawn, date of legal effect  [2006/26]
14.02.2006Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2006/26]
Request for further processing for:27.05.2005Request for further processing filed
26.05.2005Full payment received (date of receipt of payment)
Request granted
10.06.2005Decision despatched
Fees paidRenewal fee
14.10.2004Renewal fee patent year 03
28.11.2005Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.10.200504   M06   Fee paid on   28.11.2005
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO0064899  (UPJOHN CO [US], et al) [A] 1-43* abstract *;
 [XD]WO0077002  (DU PONT PHARM CO [US]) [XD] 1-43 * examples, especially no. 128, 129, 149 of table 2A; page 4, line 14 - page 5, line 11 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.